Insight I Sino Bioengineering

Mammalian cell culture stands as a core technology in modern biopharmaceutical manufacturing. A large portfolio of monoclonal antibodies (mAbs) and complex therapeutic recombinant p……

On 28 October 2026, PIC/S issued P1058-1 Interpretation of the Most Significant Changes to Annex 1 for the Manufacture of Sterile Medicinal Products. This document entered into force……

Driven by rising chip TDP and large-scale cluster rollouts, liquid cooling has evolved from an optional upgrade into a foundational infrastructure for modern AI data centres. This pa……

As artificial intelligence and high-performance computing (HPC) deployments scale rapidly, rack power densities in high-density compute environments have escalated from the conventi……

For biopharmaceutical manufacturing processes including monoclonal antibody production, mammalian cell culture and microbial fermentation, stainless steel agitator systems inside bio……

Resin cleaning represents an indispensable unit operation within biopharmaceutical downstream purification. It is engineered to remove adsorbed and entrapped process foulants, includ……

Within the evolution of biopharmaceutical upstream processing, fed-batch culture has long served as the commercial manufacturing workhorse, underpinned by its well-characterized proc……

Driven by the rapid advancement of biopharmaceutical technologies, sustained growth in the biologic drug market has raised stringent requirements for the productivity, quality and c……

With the vigorous expansion of the global biopharmaceutical sector, a growing portfolio of biologic products has advanced into commercial manufacturing. As a vital segment within the……

Antibody-drug conjugates (ADCs) represent one of the defining therapeutic modalities advancing precision oncology. As engineered biotherapeutics, ADCs leverage the antigen-recognitio……

CPHI Milan was a major talking point in the pharmaceutical industry over the past week. Numerous posts and news coverage about the exhibition circulated across social media and WeCha……

Biopharma 4.0 is underpinned by four definitive attributes: digitalization, intelligent manufacturing, operational continuity, and modularity. End-to-end continuous manufacturing rep……

The landscape of oncological therapy is undergoing profound transformation, with precision-targeted and individualized treatment modalities emerging as the core trend of innovative ……

Driven by global population expansion, surging market demand for animal-derived food products, and the large-scale, intensive transformation of livestock breeding models, the strate……

Within the pharmaceutical industry, compliance and operational efficiency are often regarded as opposing imperatives. True intelligent manufacturing, however, redefines compliance no……

Lyophilization (freeze-drying) is an indispensable core process in the manufacturing of sterile pharmaceutical products, whose contamination control performance fundamentally determ……